Volume peaking up lately, hope we hear something soon! Last time their product was on phase 2/3 . Main reason for raising the AS (said by them) was to pay employees and operating costs and more so it will not surprise me they are working on it smoothly! Some Cancer treatment and vaccines are having FDA approvals and authorizations lately which makes me think it is more publicly visible and doable for these types of companies. Maybe the cures are coming and make this cancer thing a thing from the past!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.